Skip to main contentSkip to navigation
Sirius Investors

CPIX Stock: Cumberland Pharmaceuticals Inc. Stock Price, Analysis & Insights

Get live CPIX stock price $5.67, comprehensive Cumberland Pharmaceuticals Inc. stock analysis, charts, news, and expert forecast. Real-time CPIX stock data and investment insights.

5.67
3.56%Today
CPIXCumberland Pharmaceuticals Inc. • NASDAQ Global Select • Healthcare
Market Cap
85.03M
Volume
23.33K
52W High
6.61
52W Low
1.85

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Cumberland Pharmaceuticals Inc. functions as a specialized pharmaceutical enterprise, primarily involved in the procurement, advancement, and commercialization of prescription medications. Its strategic focus areas include acute hospital care, gastro...

Company Information

CEO
A. J. Kazimi
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
91

Contact Information

Address
2525 West End Avenue
Country
US

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: 0.10) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Cumberland Pharmaceuticals Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Cumberland Pharmaceuticals Inc.
  • Investors should consider how Cumberland Pharmaceuticals Inc. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

85.03M

P/E Ratio (TTM)

-11.58

Beta

0.10

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

81/100 ⭐⭐⭐⭐⭐

Overall
+0.7%
NYSE
+0.4%
NASDAQ
+1.0%
Sector1D1W1MP/EScore
Financial Services-0.4%+1.1%+1.1%19.2
86/100⭐⭐⭐⭐⭐
Healthcare+0.7%-1.7%+1.5%30.4
81/100⭐⭐⭐⭐⭐
Industrials+1.0%-4.1%+1.6%42.2
79/100⭐⭐⭐⭐⭐
Communication Services-1.4%-2.9%-0.0%21.5
62/100⭐⭐⭐⭐
Energy-0.7%-6.6%+1.1%36.8
61/100⭐⭐⭐⭐
Basic Materials+0.3%-3.9%-1.4%26.9
49/100⭐⭐⭐
Technology+0.3%-6.7%+1.1%49.6
45/100⭐⭐⭐
Real Estate-0.6%-1.5%-1.6%49.3
27/100⭐⭐
Utilities+0.4%-4.5%-6.2%25.5
24/100
Consumer Defensive-0.5%+1.8%-2.7%31.1
22/100
Consumer Cyclical-0.5%-3.6%-2.5%53.0
14/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score: 70% 1M momentum percentile + 30% valuation percentile (lower P/E ranks higher), shown as 0–100 with stars. Data as of 2026-06-11.